Sanshentongmai Mixture Improves Oxidative Damage in Rat Cardiomyocytes H9C2 via Upregulation of microRNA-146a

LI Ran, WANG Zhenyu, WANG Yanli, TENG Fei

Abstract

To investigate the effect of Sanshentongmai (SSTM) mixture on the regulation of oxidative damage to rat cardiomyocytes (H9C2) through microRNA-146a and its mechanism.
Methods H9C2 were cultured in vitro, H2O2 was used as an oxidant to create an oxidative damage model in H9C2 cells. SSTM intervention was administered to the H9C2 cells. Then, the changes in H2O2-induced oxidative damage in H9C2 cells and the expression of microRNA-146a were observed to explore the protective effect of SSTM on H9C2 and its mechanism. H9C2 cells cultured in vitro were divided into 3 groups, including a control group, a model group of H2O2-induced oxidative damage (referred to hereafter as the model group), and a group given H2O2 modeling plus SSTM intervention at 500 μg/L for 72 h (referred to hereafter as the treatment group). The cell viability was measured by CCK8 assay. In addition, the levels of N-terminal pro-brain natriuretic peptide (Nt-proBNP), nitric oxide (NO), high-sensitivity C-reactive protein (Hs-CRP), and angiotensin were determined by enzyme-linked immunosorbent assay (ELISA). The expression level of microRNA-146a was determined by real-time PCR (RT-PCR).
Result H9C2 cells were pretreated with SSTM at mass concentrations ranging from 200 to 1500 μg/L. Then, CCK8 assay was performed to measure cell viability and the findings showed that the improvement in cell proliferation reached its peak when the mass concentration of SSTM was 500 μg/L, which was subsequently used as the intervention concentration. ELISA was performed to measure the indicators related to heart failure, including Nt-proBNP, NO, Hs-CRP, and angiotensin Ⅱ. Compared with those of the control group, the expressions of Nt-proBNP and angiotensin Ⅱ in the treatment group were up-regulated (P<0.05), while the expression of NO was down-regulated (P<0.05). There was no significant difference in the expression of Hs-CRP between the treatment group and the control group. These findings indicate that SSTM could effectively ameliorate oxidative damage in H9C2 rat cardiomyocytes. Finally, according to the RT-PCR findings for the expression of microRNA-146a in each group, H2O2 treatment at 15 μmol/L could significantly reduce the expression of microRNA-146a, and the expression of microRNA-146a in the treatment group was nearly doubled compared with that in the model group. There was no significant difference between the treatment group and the control group.
Conclusion SSTM can significantly resist the H2O2-induced oxidative damage of H9C2 cells and may play a myocardial protective role by upregulating microRNA-146a.

 

Keywords: H9C2 cell line, Sanshentongmai mixture, Oxidative damage, microRNA-146a

 

Full Text:

PDF


References


TIAN C, GAO L, RUDEBUSH T L, et al. Extracellular vesicles regulate sympatho-excitation by Nrf2 in heart failure. Circ Res, 2022, 131(8): 687–700. doi: 10.1161/CIRCRESAHA.122.320916.

WANG A J, TANG Y, ZHANG J, et al. Cardiac SIRT1 ameliorates doxorubicin-induced cardiotoxicity by targeting sestrin 2. Redox Biol, 2022, 52: 102310. doi: 10.1016/j.redox.2022.102310.

JIN M, XU X R, HUANG L J, et al. Clinical observation of SSTM on chest paralysis and heartache patients. Jilin J Tradit Chin Med, 1998, 8(1): 8–9.

WANG J, YU G. A systems biology approach to characterize biomarkers for blood stasis syndrome of unstable angina patients by integrating microrna and messenger rna expression profiling. Evid Based Complement Alternat Med, 2013, 2013: 510208. doi: 10.1155/2013/ 510208.

TENG F, WANG Z Y, LI R. Observation on the mechanism of Sanshen Tongmai Mixture on chronic heart failure rats. Beijing J Tradit Chin Med, 2023, 42(9): 958–965. doi: 10.16025/j.1674-1307.2023.09.006.

NKADIMENG S M, STEINMANN C, BOTHA C J, et al. Cardioprotective potential of the water extracts of pscilocybecubensis magic mushrooms on angiotensin Ⅱ-induced hypertrophy in rat cardiomyoblast cells. Eur J Prev Cardiol, 2020, 27 (1_ sup-pl): S119.

HO P T B, CLARK I M, LE L T T. MicroRNA-based diagnosis and therapy. Int J Mol Sci, 2022, 23(13): 7167. doi: 10.3390/ijms23137167.

WANG J, YAO K W, LIU Y M, et al. Transcriptomic studies on coronary heart disease with blood stasis syndrome—research approaches and methods in terms of biomarker and disease symptoms. Chin J Exp Tradit Med Formulae, 2017, 23(19): 1–5. doi: 10.13422/j.cnki.syfjx.2017190001.

HE F, LIU Y, LI T, et al. MicroRNA-146 attenuates lipopolysaccharide induced ovarian dysfunction by inhibiting the TLR4/NF- κB signaling pathway. Bioengineered, 2022, 13(5): 11611–11623. doi: 10.1080/ 21655979.2022.2070584.

HOU J, DENG Q, DENG X, et al. MicroRNA-146a-5p alleviates lipopolysaccharide-induced NLRP3 inflammasome injury and pro-inflammatory cytokine production via the regulation of TRAF6 and IRAK1 in human umbilical vein endothelial cells (HUVECs). Ann Transl Med, 2021, 9(18): 1433. doi: 10.21037/atm-21-3903.

LYU B, WEI Z, JIANG L, et al. MicroRNA-146a negatively regulates IL-33 in activated group 2 innate lymphoid cells by inhibiting IRAK1 and TRAF6. Genes Immun, 2020, 21(1): 37–44. doi: 10.1038/s41435-019-0084-x.

SHAN L, LIU W, ZHAN Y. LncRNA HAND2-AS1 exerts anti-oncogenic effects on bladder cancer via restoration of RARB as a sponge of microRNA-146. Cancer Cell Int, 2021, 21(1): 361. doi: 10.1186/s12935-021-02063-y.

AN R, FENG J, XI C, et al. miR-146a attenuates sepsis-induced myocardial dysfunction by suppressing IRAK1 and TRAF6 via targeting ErbB4 expression. Oxid Med Cell Longev, 2018, 2018: 7163057. doi: 10. 1155/2018/7163057.

ZHOU S, GAO X, CHEN C, et al. Porcine cardiac blood - Salvia miltiorrhiza root alleviates cerebral ischemia reperfusion injury by inhibiting oxidative stress induced apoptosis through PI3K/AKT/Bcl-2/Bax signaling pathway. J Ethnopharmacol, 2023, 316: 116698. doi: 10. 1016/j.jep.2023.116698.


Refbacks

  • There are currently no refbacks.